Chronic hemodialysis catheters are vital for patients undergoing long-term hemodialysis treatment, a life-sustaining procedure for those with end-stage renal disease (ESRD). These catheters facilitate ...

Before 1998, urokinase was considered standard therapy for the management of occluded hemodialysis catheters. The dose of 5000 units per port appears on the FDA-approved labeling for urokinase.

Faced with a dire shortage of medicines, supplies and medical personnel despite the authorities’ claims about the quality of ...

Tata Capital Healthcare Fund, the healthcare and life sciences-focused private equity arm of financial services company ...

Harsoria said it will use the funding to expand its manufacturing capabilities, improve research and development (R&D) ...

Needham analyst Serge Belanger maintained a Buy rating on Cormedix (CRMD – Research Report) today and set a price target of $18.00.Stay Ahead ...

In a report released today, Jason Butler from JMP Securities reiterated a Buy rating on Cormedix (CRMD – Research Report), with a price target ...

Shares of CorMedix CRMD rose nearly 30% on Tuesday after management announced fourth-quarter and full-year 2024 preliminary ...

including intravenous catheters, hemodialysis tubes, central venous catheters, ureteral stents, brain stimulation and much more.

dicentra congratulates SterileCare on achieving a significant milestone in their innovative catheter lock solution clinical trial, with 20 patients enrolled as of December 30, 2024. The trial, which ...